Summary
PHITHOCLACIC is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €749,829 and a net result of €55,209. Equity is shrinking by about 5.2% per year across the filed financial years. Its solvency ranks better than 57% of 6,630 sector peers (NACE 64, financial year 2025). The company has been active since 1979 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
01-07
Gazette deed
Reappointment: BV PS Consulting (director)Permanent representative: Philippe Straetmans · Power of attorney5 facts ▸
- General meeting, 16-06-2026
- Director reappointment, BV PS Consulting (director (not named in the articles))
- Permanent representative, Philippe Straetmans
- Power of attorney, BV Norgay Accountants
- Power of attorney
About the unread acts
Of the 7 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 6 have not been read yet: what they contain is neither established nor disproved here.